Read the story here. Advertise at Before It's News here.
Profile image
By idatainsights
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review – 2015 Now Available at iData Insights

% of readers think this story is Fact. Add your two cents.

Kyorin Pharmaceutical Co., Ltd. – Product Pipeline Review – 2015 Summary Global Markets Direct s, Kyorin Pharmaceutical Co., Ltd. – Product Pipeline Review – 2015, provides an overview of the Kyorin Pharmaceutical Co., Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kyorin Pharmaceutical Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope – The report provides brief overview of Kyorin Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries – The report reviews current pipeline of Kyorin Pharmaceutical Co., Ltd.s human therapeutic division and enlists all their major and minor projects – The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones – Special feature on out-licensed and partnered product portfolio – The report summarizes all the dormant and discontinued pipeline projects – Latest company statement – Latest news and deals relating to the Kyorin Pharmaceutical Co., Ltd.s pipeline products Reasons to buy – Evaluate Kyorin Pharmaceutical Co., Ltd.s strategic position with total access to detailed information on its product pipeline – Assess the growth potential of Kyorin Pharmaceutical Co., Ltd. in its therapy areas of focus – Identify new drug targets and therapeutic classes in the Kyorin Pharmaceutical Co., Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas – Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps – Develop strategic initiatives by understanding the focus areas of Kyorin Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities – Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage – Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kyorin Pharmaceutical Co., Ltd. – Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope – Explore the dormant and discontinued projects of Kyorin Pharmaceutical Co., Ltd. and identify potential opportunities in those areas – Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @

To Get Sample Copy of Report visit @

Table of Contents

Table of Contents

2 List of Tables

 5 List of Figures

5 Kyorin Pharmaceutical Co., Ltd. Snapshot

6 Kyorin Pharmaceutical Co., Ltd. Overview

6 Key Information

6 Key Facts

6 Kyorin Pharmaceutical Co., Ltd.  Research and Development Overview

7 Key Therapeutic Areas

7 Kyorin Pharmaceutical Co., Ltd.  Pipeline Review

10 Pipeline Products by Stage of Development

10 Pipeline Products  Monotherapy

11 Pipeline Products  Combination Treatment Modalities

12 Pipeline Products  Partnered Products

13 Partnered Products/Combination Treatment Modalities

14 Kyorin Pharmaceutical Co., Ltd.  Pipeline Products Glance

15 Kyorin Pharmaceutical Co., Ltd.  Late Stage Pipeline Products

15 Phase III Products/Combination Treatment Modalities

15 Kyorin Pharmaceutical Co., Ltd.  Clinical Stage Pipeline Products

16 Phase II Products/Combination Treatment Modalities

16 Kyorin Pharmaceutical Co., Ltd.  Early Stage Pipeline Products

17 IND/CTA Filed Products/Combination Treatment Modalities

17 Preclinical Products/Combination Treatment Modalities

18 Discovery Products/Combination Treatment Modalities

19 Kyorin Pharmaceutical Co., Ltd.  Drug Profiles

20 (aclidinium bromide + formoterol fumarate)

20 Product Description

20 Mechanism of Action

20 R&D Progress

20 KRPAM-1977X

22 Product Description

22 Mechanism of Action

22 R&D Progress

22 vibegron

23 Product Description

23 Mechanism of Action

23 R&D Progress

23 ibudilast

24 Product Description

24 Mechanism of Action

24 R&D Progress

24 KRP-203

26 Product Description

26 Mechanism of Action

26 R&D Progress

26 KRPAM-1977Y

28 Product Description

28 Mechanism of Action

28 R&D Progress

28 neramexane mesylate

29 Product Description

29 Mechanism of Action

29 R&D Progress

29 tipelukast

31 Product Description

31 Mechanism of Action

31 R&D Progress

31 AX-11890

33 Product Description

33 Mechanism of Action

33 R&D Progress

33 AX-13057

34 Product Description

34 Mechanism of Action

34 R&D Progress

34 KCA-1490

35 Product Description

35 Mechanism of Action

35 R&D Progress

35 Small Molecule to Inhibit PDE4 for Inflammation

36 Product Description

36 Mechanism of Action

36 R&D Progress

36 MN-002

37 Product Description

37 Mechanism of Action

37 R&D Progress

37 Kyorin Pharmaceutical Co., Ltd.  Pipeline Analysis

38 Kyorin Pharmaceutical Co., Ltd.  Pipeline Products by Target

38 Kyorin Pharmaceutical Co., Ltd.  Pipeline Products by Route of Administration

40 Kyorin Pharmaceutical Co., Ltd.  Pipeline Products by Molecule Type

41 Kyorin Pharmaceutical Co., Ltd.  Pipeline Products by Mechanism of Action

42 Kyorin Pharmaceutical Co., Ltd.  Recent Pipeline Updates

43 Kyorin Pharmaceutical Co., Ltd.  Dormant Projects

54 Kyorin Pharmaceutical Co., Ltd.  Discontinued Pipeline Products

55 Discontinued Pipeline Product Profiles

55 KRP-110

55 tipelukast

55 Kyorin Pharmaceutical Co., Ltd.  Locations And Subsidiaries

56 Head Office

56 Other Locations & Subsidiaries

56 Appendix

59 Methodology

59 Coverage

59 Secondary Research

59 Primary Research

59 Expert Panel Validation

59 Contact Us

59 Disclaimer Read More @

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm.  We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.


Contact Us: 
iData Insights

Tel: 1-866-237-2965

Email: [email protected]


About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects. 


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Report abuse


    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    Load more ...




    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.